UK Oncology Medical Affairs Lead

Regeneron Pharmaceuticals, Inc.; Uxbridge; Hybrid; GBP 110,000 - 150,000; Full time

Job summary

Regeneron Pharmaceuticals, Inc. in the UK seeks an Associate Director Medical Affairs (Oncology) to lead scientific strategy and medical leadership across oncology portfolios and pipelines.

You will partner with internal teams and external healthcare professionals to shape medical strategy and support launches. You will drive advisory boards, scientific meetings, and educational initiatives, delivering high-quality presentations and ensuring ABPI-compliant materials while collaborating across

Qualifications

• Advanced scientific degree required (MD/PhD/PharmD/ MSc or equivalent).
• Significant Medical Affairs experience in pharma/biotech with oncology focus.
• Strong knowledge of UK Medical Affairs and Clinical Development.

Responsibilities

• Act as UK medical lead for assigned oncology assets and pipeline products.
• Build and maintain scientific relationships with HCPs, KOLs, societies and external stakeholders.
• Collaborate with Clinical Development, Commercial, Regulatory, Market Access and Global Medical Affairs teams.
• Provide scientific input into product strategy, launches, lifecycle management and evidence-generation activities.
• Support advisory boards, congresses and educational initiatives.

Skills

Scientific communication

Stakeholder engagement

Strategic thinking

Analytical skills

KOL engagement

ABPI code familiarity

Cross-functional collaboration

Education

MD/PhD/PharmD/MS equivalent

Job description

Regeneron Pharmaceuticals, Inc. in the UK seeks an Associate Director Medical Affairs (Oncology) to lead scientific strategy and medical leadership across oncology portfolios and pipelines.

You will partner with internal teams and external healthcare professionals to shape medical strategy and support launches. You will drive advisory boards, scientific meetings, and educational initiatives, delivering high-quality presentations and ensuring ABPI-compliant materials while collaborating across